BD BBL SENSI-DISC RIFAMPICINAS - COFEPRIS Registration 868R2018 SSA
Access comprehensive regulatory information for BD BBL SENSI-DISC RIFAMPICINAS (BD BBL SENSI-DISC RIFAMPICINAS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 868R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on April 03, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARA PRUEBAS SEMICUANTITATIVAS DE SUSCEPTIBILIDAD IN VITRO DE MICROORGANISMOS GRAM NEGATIVOS Y/O GRAM POSITIVOS
FOR SEMI-QUANTITATIVE IN VITRO SUSCEPTIBILITY TESTING OF GRAM-NEGATIVE AND/OR GRAM-POSITIVE MICROORGANISMS